Malaysia: Oilseeds and Products Update

  |   Attaché Report (GAIN)   |   MY2021-0013

Post is adjusting its MY 2021/22 crude palm oil (CPO) production forecast down 1.5 million metric tons (MT) from the USDA Official estimate to 18.2 million MT. Acute COVID-19 related labor issues are expected to negatively impact the Malaysian palm oil industry as the Government of Malaysia (GoM) has not finalized a decision to allow foreign workers to work in the sector. As the price of CPO is expected to stabilize in 2022, CPO export is forecast to recover slightly to 16.5 million tons, though this recovery will continue to be restrained by production limitations. CPO production for MY 2020/21 is revised slightly to 17.9 million MT. Exports for MY 2020/21 are revised to 15.5 million tons, a drop of 0.6 million tons from the USDA Official estimate, as all-time high CPO prices throughout 2021 prompt some buyers to switch from palm oil to other vegetable oils. Slower than expected recovery in global vegetable oil demand due to the COVID-19 pandemic also contributed to low export demand for palm oil.

Related Reports

Attaché Report (GAIN)

Singapore: Agricultural Biotechnology Annual

Singapore does not have any domestic commercial production of plant biotechnology. The Singapore Food Agency provides a link in its website that lists a total of 57 genetically engineered (GE) crops that have been approved for use as food for direct consumption, ingredients, and further processing into ingredients for other food in the country.
Attaché Report (GAIN)

Chile: Agricultural Biotechnology Annual

This year's report does not contain significant changes from last year's report. Chile continues allowing the reproduction of seeds under strict control of the Agricultural and Livestock Service of the Ministry of Agriculture.
Attaché Report (GAIN)

Kazakhstan: Agricultural Biotechnology Annual

In the past year, there have been no major changes in Kazakhstan’s biotechnology policy. Kazakhstan continues to rely on Eurasian Economic Union (EAEU) regulations for guidance on biotechnology issues.